Incidence of invasive meticillin-resistant staphylococcusaureus infections in Germany, 2010 to 2014

Eurosurveillance

Volumn 20, Issue 46, 2015, Pages

  Walter, J ^a   Haller, S ^a   Blank, H ^a   Eckmanns, T ^a   Abu Sin, M ^a   Hermes, J ^a  

^a ROBERT KOCH INSTITUTE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGE; AGED; ARTICLE; BACTERIAL GENE; CEREBROSPINAL FLUID ANALYSIS; CHILD; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE SURVEILLANCE; DRUG SENSITIVITY; FEMALE; GENDER; GERMANY; HUMAN; INCIDENCE; INFANT; MAJOR CLINICAL STUDY; MALE; MECA GENE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; POLYMERASE CHAIN REACTION; RETROSPECTIVE STUDY; RURAL AREA; URBAN AREA; AGE DISTRIBUTION; BACTEREMIA; COMMUNITY-ACQUIRED INFECTIONS; CROSS INFECTION; DRUG EFFECTS; HEALTH SURVEY; ISOLATION AND PURIFICATION; MANDATORY PROGRAM; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MICROBIOLOGY; MIDDLE AGED; PENICILLIN RESISTANCE; PROCEDURES; RISK FACTOR; SEX RATIO; STAPHYLOCOCCAL INFECTIONS; STATISTICS AND NUMERICAL DATA; TRENDS;

METICILLIN;

ADOLESCENT; AGE DISTRIBUTION; BACTEREMIA; COMMUNITY-ACQUIRED INFECTIONS; CROSS INFECTION; FEMALE; GERMANY; HUMANS; INCIDENCE; MALE; MANDATORY PROGRAMS; METHICILLIN; METHICILLIN RESISTANCE; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MIDDLE AGED; POLYMERASE CHAIN REACTION; POPULATION SURVEILLANCE; RETROSPECTIVE STUDIES; RISK FACTORS; SEX DISTRIBUTION; STAPHYLOCOCCAL INFECTIONS;

EID: 84983486405     PISSN: 1025496X     EISSN: 15607917     Source Type: Journal    
DOI: 10.2807/1560-7917.ES.2015.20.46.30067     Document Type: Article

References (28)

1. European Centre for Disease Prevention and Control (ECDC). Antimicrobial resistance surveillance in Europe 2013 Annual Report of the European Antimicrobial Resistance Surveillance Network (EARS-Net). Stockholm: ECDC; 2014.
2. Layer F, Cuny C, Strommenger B, Werner G, Witte W. Aktuelle Daten und Trends zu Methicillin-resistenten Staphylococcus aureus (MRSA). [Current data and trends on methicillin-resistant Staphylococcus aureus (MRSA)]. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2012;55(11-12):1377-86. DOI: 10.1007/s00103-012-1560-x PMID: 23114436
3. Robert Koch-Institut (RKI). Infektionsepidemiologisches Jahrbuch meldepflichtiger Krankheiten für 2012. Berlin: RKI; 2013. German.
4. Eckmanns T, Richter D, Feig M. MRSA und ESBL in der ambulanten Versorgung: Entwicklung in den Jahren 2008 bis 2012 sowie soziodemografische Unterschiede. [MRSA and ESBL in outpatient: development from 2008 up to 2012 and socio demographic differences]. Berl Munch Tierarztl Wochenschr. 2014;127(9-10):399-402. PMID: 25868167
5. Köck R, Schaumburg F, Mellmann A, Köksal M, Jurke A, Becker K, et al. Livestock-associated methicillin-resistant Staphylococcus aureus (MRSA) as causes of human infection and colonization in Germany. PLoS ONE. 2013;8(2):e55040. DOI: 10.1371/journal.pone.0055040 PMID: 23418434
6. Meyer E, Schröder C, Gastmeier P, Geffers C. The reduction of nosocomial MRSA infection in Germany: an analysis of data from the Hospital Infection Surveillance System (KISS) between 2007 and 2012. Dtsch Arztebl Int. 2014;111(19):331-6. PMID: 24875457
7. Noll I, Schweickert B, Abu Sin M, Feig M, Claus H, Eckmanns T. Daten zur Antibiotikaresistenzlage in Deutschland. [Antimicrobial Resistance in Germany]. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2012;55(11- 12):1370-6. DOI: 10.1007/s00103-012-1559-3 PMID: 23114435
8. Communicable Diseases Law,. 20. Juli 2000 (BGBl. I S. 1045), last changed by article 2 paragraph 36 and article 4 paragraph 21 of the law from 7. August 2013 (BGBl. I S. 3154). Amended for MRSA by the “Labormeldepflicht-Anpassungsverordnung”, 26. Mai 2009 (BGBl. I S. 1139). Bundesgesetzblatt.2000;1:1045.
9. Schweickert B, Noll I, Feig M, Claus H, Krause G, Velasco E, et al. MRSA-surveillance in Germany: data from the Antibiotic Resistance Surveillance System (ARS) and the mandatory surveillance of MRSA in blood. Eur J Clin Microbiol Infect Dis. 2012;31(8):1855-65. DOI: 10.1007/s10096-011-1511-8 PMID: 22210264
10. Haller S, Eckmanns T, Benzler J, Tolksdorf K, Claus H, Gilsdorf A, et al. Results from the first 12 months of the national surveillance of healthcare associated outbreaks in Germany, 2011/2012. PLoS ONE. 2014;9(5):e98100. DOI: 10.1371/journal.pone.0098100 PMID: 24875674
11. von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP, et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. J Clin Epidemiol. 2008;61(4):344-9. DOI: 10.1016/j.jclinepi.2007.11.008 PMID: 18313558
12. Heudorf U, Otto U, Gottschalk R. MRSA in Blutkulturen in Frankfurter Krankenhäusern 2010. [MRSA bloodstream infections in hospitals in Frankfurt/Main, Germany, 2010]. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2011;54(9):1126-34. DOI: 10.1007/s00103-011-1349-3 PMID: 21887627
13. Mielke M. Bericht über das 3. Treffen der Moderatoren der Regionalen MRE-Netzwerke am 15. und 16. Dezember 2011 am Robert Koch-Institut. [Report of the third meeting of the coordinators of the regional MRP networks in Germany on 15 and 16 December 2011 at the Robert Koch Institute].Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2012;55(11-12):1474-82. DOI: 10.1007/s00103-012-1553-9 PMID: 23114447
14. Herrmann M, Petit C, Dawson A, Biechele J, Halfmann A, vonMüller L, et al. Methicillin-resistant Staphylococcus aureus in Saarland, Germany: a statewide admission prevalence screening study. PLoS ONE. 2013;8(9):e73876. DOI: 10.1371/journal.pone.0073876 PMID: 24040103
15. Mehraj J, Akmatov MK, Strömpl J, Gatzemeier A, Layer F, Werner G, et al. Methicillin-sensitive and methicillin-resistant Staphylococcus aureus nasal carriage in a random sample of non-hospitalized adult population in northern Germany. PLoS ONE. 2014;9(9):e107937. DOI: 10.1371/journal.pone.0107937 PMID: 25251407
16. Gruber I, Heudorf U, Werner G, Pfeifer Y, Imirzalioglu C, Ackermann H, et al. Multidrug-resistant bacteria in geriatric clinics, nursing homes, and ambulant care--prevalence and risk factors. Int J Med Microbiol. 2013;303(8):405-9. DOI: 10.1016/j.ijmm.2013.05.002 PMID: 23770266
17. Wyllie D, Paul J, Crook D. Waves of trouble: MRSA strain dynamics and assessment of the impact of infection control. J Antimicrob Chemother. 2011;66(12):2685-8. DOI: 10.1093/jac/dkr392 PMID: 21948966
18. Gastmeier P, Schwab F, Behnke M, Geffers C. Wenige Blutkulturproben – wenige Infektionen? [Less blood culture samples: less infections?]. Anaesthesist. 2011;60(10):902-7. DOI: 10.1007/s00101-011-1889-9 PMID: 21874374
19. Grundmann H, Schouls LM, Aanensen DM, Pluister GN, Tami A, Chlebowicz M, et al. The dynamic changes of dominant clones of Staphylococcus aureus causing bloodstream infections in the European region: results of a second structured survey. Euro Surveill. 2014;19(49):20987. DOI: 10.2807/1560-7917.ES2014.19.49.20987 PMID: 25523972
20. Layer F, Strommenger B, Cuny C. Eigenschaften, Häufigkeiten und Verbreitung von MRSA in Deutschland, Update 2013/2014. Epidemiologisches Bulletin.2015;31. German.
21. Bundesamt für Verbraucherschutz und Lebensmittelsicherheit. Paul-Ehrlich-Gesellschaft für Chemotherapie e.V., Freiburg I. GERMAP 2012 Antibiotika-Resistenz und -Verbrauch Bericht über den Antibiotikaverbrauch und die Verbreitung von Antibiotikaresistenzen in der Human- und Veterinärmedizin in Deutschland. Antiinfectives Intelligence; 2014.
22. DANMAP. Use of antimicrobial agents and occurrence of antimicrobial resistance in bacteria from food animals, food and humans in Denmark; 2014. Available from: http://www.danmap.org/~/media/projekt%20sites/danmap/danmap%20reports/danmap%202014/danmap_2014.ashx
23. Laupland KB, Lyytikäinen O, Søgaard M, Kennedy KJ, Knudsen JD, Ostergaard C, et al. The changing epidemiology of Staphylococcus aureus bloodstream infection: a multinational population-based surveillance study. Clin Microbiol Infect. 2013;19(5):465-71. DOI: 10.1111/j.1469-0691.2012.03903.x. PMID: 22616816
24. Public Health England (PHE). Annual Epidemiological Commentary: Mandatory MRSA, MSSA and E. coli bacteraemia and C. difficile infection data, 2013/14. London: PHE; 2014. [Accessed 22 Feb 2015]. Available from: https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/330529/HCAI_mandatory_surveillance:annual_epidemiological_commentary_2013_14.pdf
25. Kallen AJ, Mu Y, Bulens S, Reingold A, Petit S, Gershman K, et al. Health care-associated invasive MRSA infections, 2005-2008. JAMA. 2010;304(6):641-8. DOI: 10.1001/jama.2010.1115. PMID: 20699455
26. De Kraker MEA, Wolkewitz M, Davey PG, Grundman H; on behalf of the BURDEN Study Group, et al. Clinical impact of antimicrobial resistance in European hospitals: excess mortality and length of hospital stay related to methicillinresistant Staphylococcus aureus bloodstream infections. Antimicrob Agents Chemother. 2011;55(4):1598-605. DOI: 10.1128/AAC.01157-10. PMID: 21220533
27. Cosgrove SE, Sakoulas G, Perencevich EN, Schwaber MJ, Karchmer AW, Carmeli Y. Comparison of mortality associated with methicillin-resistant and methicillin-susceptible Staphylococcus aureus bacteremia: a meta-analysis. Clin Infect Dis. 2003;36(1):53-9. DOI: 10.1086/345476. PMID: 12491202
28. Tom S, Galbraith JC, Valiquette L, Jacobsson G, Collignon P, Schønheyder HC, et al. Case fatality ratio and mortality rate trends of community-onset Staphylococcus aureus bacteraemia. Clin Microbiol Infect. 2014;20(10):O630-2. DOI: 10.1111/1469-0691.12564. PMID: 24461038